MARKET

CYAD

CYAD

Celyad
NASDAQ

Real-time Quotes | Nasdaq Last Sale

8.50
+0.21
+2.53%
After Hours: 8.50 0 0.00% 16:35 04/09 EDT
OPEN
8.30
PREV CLOSE
8.29
HIGH
8.50
LOW
8.30
VOLUME
1.00K
TURNOVER
--
52 WEEK HIGH
22.48
52 WEEK LOW
4.100
MARKET CAP
118.51M
P/E (TTM)
-3.3166
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average CYAD stock price target is 27.25 with a high estimate of 36.89 and a low estimate of 19.94.

EPS

CYAD News

More
  • What Makes Celyad SA (CYAD) a New Buy Stock
  • Zacks · 03/31 17:00
  • Imagine Owning Celyad (EBR:CYAD) And Trying To Stomach The 84% Share Price Drop
  • Simply Wall St. · 03/26 09:42
  • Celyad SA (CYAD) CEO Filippo Petti on Q4 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript · 03/26 05:34
  • Celyad SA to Host Earnings Call
  • ACCESSWIRE · 03/25 15:00

Industry

Biotechnology & Medical Research
+1.63%
Pharmaceuticals & Medical Research
+0.82%

Hot Stocks

Symbol
Price
%Change

About CYAD

Celyad SA, formerly Cardio3 Biosciences SA is a Belgium-based drug developing company. The Company develops stem cell-based therapies for cardiovascular disease. The Company focuses on developing regenerative therapies to treat illnesses where cardiac tissue is lost due to chronic or acute injury. The Company's product, C-Cure, allows the differentiation of a patient's own cells into cardiopoeitic cells which grow into new heart cells and repair heart muscle. C-Cure consists of autologous adult stem cells guided in vitro to the cardiac lineage before implantation in the failing heart. Furthermore, the Company is involved in the field of immuno-oncology, through its subsidiary, OnCyte.
More

Webull offers kinds of Celyad SA stock information, including NASDAQ:CYAD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CYAD stock news, and many more online research tools to help you make informed decisions.